Cargando…
Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis
BACKGROUND AIMS: Autologous macrophage therapy represents a potentially significant therapeutic advance for the treatment of severe progressive liver cirrhosis. Administration of macrophages has been shown to reduce inflammation and drive fibrotic scar breakdown and tissue repair in relevant models....
Autores principales: | Fraser, Alasdair R., Pass, Chloe, Burgoyne, Paul, Atkinson, Anne, Bailey, Laura, Laurie, Audrey, W.A. McGowan, Neil, Hamid, Akib, Moore, Joanna K., Dwyer, Benjamin J., Turner, Marc L., Forbes, Stuart J., Campbell, John D.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571439/ https://www.ncbi.nlm.nih.gov/pubmed/28673774 http://dx.doi.org/10.1016/j.jcyt.2017.05.009 |
Ejemplares similares
-
Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
por: Romagnoli, Luca, et al.
Publicado: (2011) -
Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study
por: Moore, Joanna K., et al.
Publicado: (2015) -
Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
por: Cooper, Rachel S., et al.
Publicado: (2021) -
GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
por: Fernández, Lucía, et al.
Publicado: (2019) -
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD(2) and Releasing Inducible IL-18
por: Glienke, Wolfgang, et al.
Publicado: (2022)